These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20886248

  • 1. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
    Gkouva L, Andrikoula M, Kontogeorgakos V, Papachristou DJ, Tsatsoulis A.
    Clin Rheumatol; 2011 Jan; 30(1):139-44. PubMed ID: 20886248
    [Abstract] [Full Text] [Related]

  • 2. Paget's disease of the bone: a report of three cases.
    Bhatt K, Balakrishnan C, Mangat G, Bajan K, Ashavaid T, Joshi VR.
    J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
    [Abstract] [Full Text] [Related]

  • 3. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Jul; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 4. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C, Feichtinger X, Haschka J, Kocijan R.
    Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
    [Abstract] [Full Text] [Related]

  • 6. Polyostotic Paget's disease.
    Butt ST, Fatima S, Butt R, Nasir W, Jameel G, Irfan J.
    J Coll Physicians Surg Pak; 2012 Jul; 22(7):461-3. PubMed ID: 22747870
    [Abstract] [Full Text] [Related]

  • 7. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 8. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH.
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Paget's disease: case report].
    Wegierska M, Ignaczak P, Zalewska J, Jeka S.
    Ann Acad Med Stetin; 2011 Jul; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 20. Paget's disease with craniofacial and skeletal bone involvement.
    Rai NP, Anekar J, Mustafa SM, Devang Divakar D.
    BMJ Case Rep; 2016 Sep 01; 2016():. PubMed ID: 27587747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.